{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:35:11Z","timestamp":1790778911197,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Genomictee.inc","award":["1234"],"award-info":[{"award-number":["1234"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13148-019-0642-0","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T16:06:01Z","timestamp":1552665961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA"],"prefix":"10.1186","volume":"11","author":[{"given":"Yoon Dae","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Jeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Ha","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn Nam","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungwhan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0639-5632","authenticated-orcid":false,"given":"Nam Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"issue":"2","key":"642_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1158\/1541-7786.MCR-06-0034","volume":"5","author":"F Model","year":"2007","unstructured":"Model F, Osborn N, Ahlquist D, Gruetzmann R, Molnar B, Sipos F, et al. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. Mol Cancer Res. 2007;5(2):153\u201363.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"642_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"642_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S1470-2045(05)70422-8","volume":"6","author":"JJ Sung","year":"2005","unstructured":"Sung JJ, Lau JY, Goh KL, Leung WK. Asia Pacific Working Group on Colorectal Cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6(11):871\u20136.","journal-title":"Lancet Oncol"},{"key":"642_CR4","unstructured":"Korean Statistical Information Service. \n                    http:\/\/www.kosis.kr\n                    \n                  ."},{"key":"642_CR5","first-page":"277","volume":"6","author":"RH Dashwood","year":"1999","unstructured":"Dashwood RH. Early detection and prevention of colorectal cancer. Oncol Rep. 1999;6:277\u201381.","journal-title":"Oncol Rep"},{"key":"642_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.clinbiochem.2014.04.019","volume":"47","author":"MR Carroll","year":"2014","unstructured":"Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem. 2014;47:921\u201339.","journal-title":"Clin Biochem"},{"issue":"6","key":"642_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3748\/wjg.v13.i6.950","volume":"13","author":"ZH Huang","year":"2007","unstructured":"Huang ZH, Li LH, Yang F, Wang JF. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol. 2007;13(6):950\u20134.","journal-title":"World J Gastroenterol"},{"key":"642_CR8","doi-asserted-by":"publisher","unstructured":"Niu F, Wen J, Fu X, Li C, Zhao R, Wu S, et al. Stool DNA test of methylated syndecan-2 for the early detection of colorectal neoplasia. Cancer Epidemiol Biomark Prev. 2017; \n                    https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-0153\n                    \n                  .","DOI":"10.1158\/1055-9965.EPI-17-0153"},{"issue":"2","key":"642_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.gastro.2005.05.056","volume":"129","author":"T Morikawa","year":"2005","unstructured":"Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratoti Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterol. 2005;129(2):422\u20138.","journal-title":"Gastroenterol"},{"key":"642_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/PAT.0b013e3283502fdf","volume":"44","author":"BM Berger","year":"2012","unstructured":"Berger BM, Ahlquist DA. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology. 2012;44:80\u20138.","journal-title":"Pathology"},{"key":"642_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-230X(08)60702-2","volume":"72","author":"SB Baylin","year":"1998","unstructured":"Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141\u201396.","journal-title":"Adv Cancer Res"},{"issue":"20","key":"642_CR12","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.3748\/wjg.v20.i20.6329","volume":"20","author":"H Zhang","year":"2014","unstructured":"Zhang H, Zhu Y, Wu Y, Zhang P, Qi J. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer. World J Gastroenterol. 2014;20(20):6329\u201335.","journal-title":"World J Gastroenterol"},{"issue":"35","key":"642_CR13","doi-asserted-by":"publisher","first-page":"10057","DOI":"10.3748\/wjg.v21.i35.10057","volume":"21","author":"T Kadiyska","year":"2015","unstructured":"Kadiyska T, Nossikoff A. Stool DNA methylation assays in colorectal cancer screening. World J Gastroenterol. 2015;21(35):10057\u201361.","journal-title":"World J Gastroenterol"},{"key":"642_CR14","doi-asserted-by":"publisher","unstructured":"Vedeld HM, Goel A, Lind GE. Epigenetic biomarkers in gastrointestinal cancers: the current state and clinical perspectives. Sem Cancer Biol. 2017; \n                    https:\/\/doi.org\/10.1016\/j.semcancer.2017.12.004\n                    \n                  .","DOI":"10.1016\/j.semcancer.2017.12.004"},{"issue":"14","key":"642_CR15","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","volume":"370","author":"TF Imperiale","year":"2014","unstructured":"Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. New Eng J Med. 2014;370(14):1287\u201397.","journal-title":"New Eng J Med"},{"key":"642_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13148-017-0426-3","volume":"9","author":"TJ Oh","year":"2017","unstructured":"Oh TJ, Oh HI, Seo YY, Jeong D, Kim C, Kang HW, et al. Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer. Clin Epigenetics. 2017;9:126.","journal-title":"Clin Epigenetics"},{"issue":"4","key":"642_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3748\/wjg.14.524","volume":"14","author":"DR Wang","year":"2008","unstructured":"Wang DR, Tang D. Hypermethylated sFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening. World J Gastroenterol. 2008;14(4):524\u201331.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"642_CR18","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1158\/0008-5472.CAN-08-0142","volume":"69","author":"SC Gl\u00f6ckner","year":"2009","unstructured":"Gl\u00f6ckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 2009;69(11):4691\u20139.","journal-title":"Cancer Res"},{"issue":"15","key":"642_CR19","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/jnci\/dji204","volume":"97","author":"WD Chen","year":"2005","unstructured":"Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst. 2005;97(15):1124\u201332.","journal-title":"J Natl Cancer Inst"},{"key":"642_CR20","doi-asserted-by":"publisher","unstructured":"Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, Taylor WR, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterol. 2012; \n                    https:\/\/doi.org\/10.1053\/j.gastro.2011.10.031\n                    \n                  .","DOI":"10.1053\/j.gastro.2011.10.031"},{"issue":"15","key":"642_CR21","first-page":"869","volume":"6","author":"M Vacante","year":"2018","unstructured":"Vacante M, Borzi MB, Basile F, Biondi A. Biomarkers in colorectal cancer: Current utility and future perspectives. World J Gastroenterol. 2018;6(15):869\u201381.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"642_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.jmoldx.2013.03.004","volume":"15","author":"T Oh","year":"2013","unstructured":"Oh T, Kim N, Moon Y, Kim MS, Hoehn BD, Park CH, et al. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. J Mol Diagn. 2013;15(4):498\u2013507.","journal-title":"J Mol Diagn"},{"key":"642_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2407-14-54","volume":"14","author":"SM Mitchell","year":"2014","unstructured":"Mitchell SM, Ross JP, Drew HR, Ho T, Brown GS, Saunders NF, et al. A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer. 2014;14:54.","journal-title":"BMC Cancer"},{"key":"642_CR24","doi-asserted-by":"publisher","unstructured":"Mitchell SM, Ho T, Brown GS, Baker RT, Thomas ML, McEvoy A, et al. Evaluation of methylation biomarkers for detection of circulating tumor DNA and application to colorectal cancer. Genes (Basel). 2016; \n                    https:\/\/doi.org\/10.3390\/genes7120125\n                    \n                  .","DOI":"10.3390\/genes7120125"},{"issue":"7","key":"642_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180809","volume":"12","author":"SL Rasmussen","year":"2017","unstructured":"Rasmussen SL, Krarup HB, Sunesen MB, Johansen MB, Stender MT, Perderson IS, et al. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection. PLoS One. 2017;12(7):e0180809.","journal-title":"PLoS One"},{"issue":"9","key":"642_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1080\/15592294.2017.1356957","volume":"12","author":"BK Bartak","year":"2017","unstructured":"Bartak BK, Kalmar A, Peterfia B, Patai AV, Galamb O, Valcz G, et al. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA in plasma samples. Epigenetics. 2017;12(9):751\u201363.","journal-title":"Epigenetics"},{"key":"642_CR27","doi-asserted-by":"publisher","unstructured":"Bartak BK, Kalmar A, Galamb O, Wichmann B, Nagy ZB, Tulassay Z, et al. Blood collection and cell-free DNA isolation methods influence the sensitivity of liquid biopsy analysis for colorectal cancer detection. Pathol Oncol Res. 2018; \n                    https:\/\/doi.org\/10.1007\/s12253-018-0382-z\n                    \n                  .","DOI":"10.1007\/s12253-018-0382-z"},{"issue":"34","key":"642_CR28","first-page":"EP17","volume":"24","author":"PA Wayne","year":"2012","unstructured":"Wayne PA, CLSI. Protocols for determination of limits of detection and limits of quantitation: approved guideline. CLSI document. 2012;24(34):EP17\u2013A2.","journal-title":"CLSI document"},{"key":"642_CR29","first-page":"EP05","volume-title":"Evaluation of precision of quantitative measurement procedures; approved guideline-3rd Ed","author":"RJ McEnroe","year":"2014","unstructured":"McEnroe RJ, Durham AP, Goldford MD, Kondratovich MV, Lababidi S, Magari R et al. Evaluation of precision of quantitative measurement procedures; approved guideline-3rd Ed. 2014;34(13):EP05-EPA3."},{"issue":"22","key":"642_CR30","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1056\/NEJM200011303432203","volume":"343","author":"JS Mandel","year":"2000","unstructured":"Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. New Eng J Med. 2000;343(22):1603\u20137.","journal-title":"New Eng J Med"},{"issue":"7","key":"642_CR31","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1158\/1055-9965.EPI-07-2838","volume":"19","author":"JA Shapiro","year":"2008","unstructured":"Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomark Prev. 2008;19(7):1623\u201330.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"642_CR32","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00384-012-1428-4","volume":"27","author":"J Myong","year":"2012","unstructured":"Myong J, Shin J, Kim S. Factors associated with participation in colorectal cancer screening in Korea: the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV). Int J Color Dis. 2012;27:1061\u20139.","journal-title":"Int J Color Dis"},{"key":"642_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.7326\/0003-4819-137-2-200207160-00014","volume":"137","author":"U.S. Preventive Services Task Force","year":"2002","unstructured":"U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and Rationale. Ann Inter Med. 2002;137:129\u201331.","journal-title":"Ann Inter Med"},{"issue":"8","key":"642_CR34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/GIM.0b013e3182180c71","volume":"13","author":"DP Taylor","year":"2011","unstructured":"Taylor DP, Canon-Albright LA, Sweeney C, Williams MS, Haug PJ, Mitchell JA, et al. Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med. 2011;13(8):737\u201343.","journal-title":"Genet Med"},{"issue":"9","key":"642_CR35","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1373\/clinchem.2013.221044","volume":"60","author":"NT Potter","year":"2014","unstructured":"Potter NT, Hurban P, White MN, Whitlock KD, Lofton-Day CE, Tetzner R, et al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem. 2014;60(9):1183\u201391.","journal-title":"Clin Chem"},{"issue":"3","key":"642_CR36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cgh.2011.10.008","volume":"10","author":"DA Ahlquist","year":"2012","unstructured":"Ahlquist DA, Taylor WR, Mahoney DW, Zou H, Domanico M, Thibodeau SN, et al. The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol. 2012;10(3):272\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"642_CR37","doi-asserted-by":"publisher","unstructured":"Stracci F, Zorzi M, Grazzini G. Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health. 2014; \n                    https:\/\/doi.org\/10.3389\/fpubh.2014.00210\n                    \n                  .","DOI":"10.3389\/fpubh.2014.00210"},{"issue":"4","key":"642_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S1525-1578(10)60536-3","volume":"6","author":"D Whitney","year":"2004","unstructured":"Whitney D, Skoletsky J, Moore K, Boynton K, Kann L, Brand R, et al. Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal screening test. J Mol Diag. 2004;6(4):386\u201395.","journal-title":"J Mol Diag"},{"key":"642_CR39","doi-asserted-by":"publisher","unstructured":"Roperch JP, Benzekri B, Mansour H, Incitti R. Improved amplification efficiency on stool samples by addition of spermidine and its use for non-invasive detection of colorectal cancer. BMC Biotechnol. 2015; \n                    https:\/\/doi.org\/10.1186\/s12896-015-0148-6\n                    \n                  .","DOI":"10.1186\/s12896-015-0148-6"},{"issue":"2","key":"642_CR40","first-page":"337","volume":"4","author":"A Loktionov","year":"1998","unstructured":"Loktionov A, O\u2019Neill IK, Silvester KR, Cummings JH, Middleton SJ, Miller R. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer. Clin Cancer Res. 1998;4(2):337\u201342.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"642_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJM200007203430301","volume":"343","author":"DA Lieberman","year":"2000","unstructured":"Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. New Eng J Med. 2000;343(3):162\u20138.","journal-title":"New Eng J Med"},{"issue":"6","key":"642_CR42","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3892\/or.2014.3133","volume":"31","author":"Y Chong","year":"2014","unstructured":"Chong Y, Mai-Jan K, Ryu H, Addul-Ghafar J, Munkhdelger J, Lkhagvadorj S, et al. DNA methylation status of a distinctively different subset of genes is associated with each histologic Lauren classification subtype in early gastric carcinogenesis. Oncol Rep. 2014;31(6):2535\u201344.","journal-title":"Oncol Rep"},{"key":"642_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10620-014-3451-5","volume":"60","author":"DA Ahlquist","year":"2015","unstructured":"Ahlquist DA. Multi-target stool DNA test: a new high bar for noninvasive screening. Dig Dis Sci. 2015;60:623\u201333.","journal-title":"Dig Dis Sci"},{"issue":"Database issue","key":"642_CR44","doi-asserted-by":"publisher","first-page":"D856","DOI":"10.1093\/nar\/gku1151","volume":"43","author":"WY Huang","year":"2015","unstructured":"Huang WY, Hsu SD, Huang HY, Sun YM, Chou CH, Weng SL, et al. MethHC: a database of DNA methylation and gene expression in human cancer. Nucleic Acids Res. 2015;43(Database issue):D856\u201361.","journal-title":"Nucleic Acids Res"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-019-0642-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13148-019-0642-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-019-0642-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:06:19Z","timestamp":1584144379000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-019-0642-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1186\/s13148-019-0642-0","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"assertion":[{"value":"10 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of College of Medicine of Yonsei University College of Medicine (IRB No. 1\u20132016-0068).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TaeJeong Oh and Sungwhan An are employees of Genomictree, Inc. TaeJeong Oh and Sungwhan An are shareholders of Genomictree, Inc. The other authors state no other conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"51"}}